Free Trial

VistaGen Therapeutics (VTGN) Institutional Ownership

VistaGen Therapeutics logo
$0.24 -0.01 (-4.10%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$0.24 0.00 (-0.04%)
As of 10/9/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for VistaGen Therapeutics (NASDAQ:VTGN)

Current
Institutional Ownership
Percentage
78.39%
Number of
Institutional Buyers
(last 12 months)
19
Total
Institutional Inflows
(last 12 months)
$2.42M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$5.30M
Get VTGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling VistaGen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

VTGN Institutional Buying and Selling by Quarter

VistaGen Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026ADAR1 Capital Management LLC351,141$79K0.0%N/A0.791%
8/7/2026BlackRock Inc.345,432$78K0.0%N/A0.778%
5/18/2026ADAR1 Capital Management LLC751,141$429K0.0%+49.2%1.896%
5/16/2026Orbimed Advisors LLC3,060,000$1.75M0.0%-1.5%7.723%
5/14/2026Renaissance Technologies LLC291,300$166K0.0%+81.2%0.735%
4/28/2026AdvisorShares Investments LLC277,110$158K0.0%+10.8%0.699%
2/26/2026Seven Fleet Capital Management LP62,701$42K0.0%N/A0.158%
2/23/2026Virtu Financial LLC37,739$25K0.0%N/A0.095%
2/18/2026Ikarian Capital LLC519,077$344K0.0%-16.4%1.314%
2/18/2026Tudor Investment Corp ET AL76,172$50K0.0%N/A0.193%
2/18/2026Millennium Management LLC197,045$130K0.0%+853.0%0.499%
2/18/2026Boothbay Fund Management LLC134,571$89K0.0%-31.7%0.341%
2/17/2026Luminus Management LLC350,000$232K0.2%N/A0.883%
2/16/2026OMERS ADMINISTRATION Corp103,400$68K0.0%N/A0.261%
2/13/2026State Street Corp121,114$80K0.0%+25.0%0.307%
2/12/2026Renaissance Technologies LLC160,791$106K0.0%-61.9%0.407%
2/12/2026Dimensional Fund Advisors LP151,874$101K0.0%+123.3%0.385%
2/10/2026AdvisorShares Investments LLC250,188$166K0.0%+20.9%0.634%
2/9/2026Geode Capital Management LLC352,836$234K0.0%+18.3%0.893%
1/1/2026JPMorgan Chase & Co.271,825$965K0.0%-63.7%0.688%
11/17/2025Millennium Management LLC20,676$73K0.0%N/A0.067%
11/17/2025Bank of America Corp DE34,657$123K0.0%+926.0%0.113%
11/17/2025Boothbay Fund Management LLC197,024$699K0.0%+10.8%0.642%
11/14/2025Schonfeld Strategic Advisors LLC10,883$39K0.0%N/A0.035%
11/14/2025Occudo Quantitative Strategies LP42,704$152K0.0%N/A0.139%
11/14/2025ADAR1 Capital Management LLC113,062$401K0.0%-73.1%0.369%
11/14/2025Two Sigma Investments LP289,409$1.03M0.0%+223.5%0.943%
11/13/2025Blair William & Co. IL12,573$45K0.0%-85.4%0.041%
11/12/2025Dimensional Fund Advisors LP68,017$241K0.0%+56.9%0.222%
11/7/2025GSA Capital Partners LLP31,486$112K0.0%N/A0.103%
11/7/2025Vanguard Group Inc.1,687,735$5.99M0.0%-4.1%5.501%
11/7/2025JPMorgan Chase & Co.271,825$965K0.0%-63.7%0.886%
11/5/2025AdvisorShares Investments LLC206,998$735K0.1%+1.9%0.675%
8/14/2025Jane Street Group LLC95,051$190K0.0%N/A0.310%
8/14/2025Stempoint Capital LP2,413,254$4.83M1.5%+2.0%7.866%
8/13/2025Marshall Wace LLP34,638$69K0.0%N/A0.113%
8/11/2025Persistent Asset Partners Ltd86,819$174K0.1%-28.6%0.283%
8/4/2025AdvisorShares Investments LLC203,114$406K0.1%+27.7%0.680%
7/24/2025Blair William & Co. IL85,866$172K0.0%-14.9%0.294%
5/16/2025ADAR1 Capital Management LLC420,765$1.05M0.2%+246.4%1.458%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
5/15/2025Cubist Systematic Strategies LLC10,088$25K0.0%N/A0.035%
2/17/2025Two Sigma Advisers LP12,032$35K0.0%N/A0.043%
2/17/2025Two Sigma Investments LP137,334$405K0.0%+123.2%0.493%
2/17/2025Stempoint Capital LP2,328,492$6.87M1.7%+26.1%8.364%
2/17/2025Man Group plc18,338$54K0.0%N/A0.066%
2/17/2025Millennium Management LLC38,732$114K0.0%+52.9%0.139%
2/17/2025Bank of America Corp DE21,141$62K0.0%+1,068.0%0.076%
2/17/2025Almitas Capital LLC254,655$751K0.2%N/A0.915%
2/14/2025AdvisorShares Investments LLC99,810$294K0.1%+47.3%0.359%
2/14/2025Nantahala Capital Management LLC1,981,980$5.85M0.3%+30.6%7.119%
2/14/2025Northern Trust Corp45,211$133K0.0%-8.5%0.162%
2/14/2025Boothbay Fund Management LLC22,415$66K0.0%N/A0.081%
2/13/2025Renaissance Technologies LLC83,700$247K0.0%-56.1%0.301%
2/13/2025ADAR1 Capital Management LLC121,461$358K0.1%-25.5%0.436%
2/12/2025Landscape Capital Management L.L.C.41,804$123K0.0%N/A0.150%
2/12/2025Blair William & Co. IL98,466$290K0.0%+11.3%0.354%
2/12/2025JPMorgan Chase & Co.772,244$2.28M0.0%+4,826,425.0%2.774%
2/7/2025Prosperity Wealth Management Inc.29,250$86K0.0%N/A0.105%
1/23/2025R Squared Ltd8,610$25K0.0%N/A0.031%
11/20/2024Virtu Financial LLC20,210$61K0.0%+30.5%0.073%
11/16/2024Geode Capital Management LLC258,524$778K0.0%-10.9%0.929%
11/15/2024Jane Street Group LLC19,659$59K0.0%N/A0.071%
11/15/2024HighTower Advisors LLC20,828$64K0.0%N/A0.075%
11/13/2024Great Point Partners LLC674,075$2.03M0.6%-55.9%2.421%
11/12/2024Valence8 US LP34,376$103K0.0%N/A0.127%
8/15/2024Armistice Capital LLC300,000$1.04M0.0%-17.6%1.109%
8/14/2024Great Point Partners LLC1,529,338$5.32M1.0%-17.7%5.652%
8/12/2024Blair William & Co. IL88,466$308K0.0%+29.2%0.327%
8/9/2024Renaissance Technologies LLC64,900$226K0.0%-40.9%0.240%
8/8/2024American Century Companies Inc.30,315$105K0.0%+49.1%0.112%
8/8/2024AdvisorShares Investments LLC51,780$185K0.0%-28.2%0.192%
5/14/2024StemPoint Capital LP1,848,582$9.29M2.5%+3.3%6.842%
5/10/2024Acadian Asset Management LLC32,291$169K0.0%N/A0.120%
5/10/2024Vanguard Group Inc.1,793,166$9.47M0.0%-2.3%6.635%
5/9/2024Blair William & Co. IL68,466$362K0.0%-22.2%0.253%
2/15/2024Great Point Partners LLC1,858,735$9.55M1.6%N/A6.879%
2/15/2024BVF Inc. IL2,000,000$10.28M0.3%N/A7.402%
2/14/2024ADAR1 Capital Management LLC245,502$1.26M0.5%N/A0.909%
2/14/2024AdvisorShares Investments LLC54,311$279K0.1%N/A0.201%
2/13/2024Tower Research Capital LLC TRC9,298$48K0.0%N/A0.034%
2/13/2024Armistice Capital LLC478,000$2.46M0.0%N/A1.769%
1/30/2024BML Capital Management LLC150,000$771K0.6%+50.0%0.555%
11/14/2023Schonfeld Strategic Advisors LLC138,500$726K0.0%N/A1.480%
11/9/2023Blair William & Co. IL85,173$446K0.0%N/A0.910%
10/24/2023Raymond James & Associates10,000$52K0.0%N/A0.107%
10/23/2023BML Capital Management LLC100,000$524K0.5%N/A1.068%
4/13/2023Allspring Global Investments Holdings LLC212,443$26K0.0%N/A0.097%
4/11/2023Henrickson Nauta Wealth Advisors Inc.200,000$25K0.0%N/A0.091%
2/13/2023GSA Capital Partners LLP5,095,354$525K0.1%-2.4%2.323%
2/9/2023MAI Capital Management617,733$64K0.0%-66.7%0.299%
No. 1 stock to cash in on the death of iPhone (Ad)

Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel

Get the free ticker and see Baylin's full research now
1/27/2023GPS Wealth Strategies Group LLC253,205$25K0.0%+3,444.8%0.122%
11/7/2022Virtu Financial LLC230,742$35K0.0%N/A0.112%
8/16/2022Commodore Capital LP13,049,079$11.48M2.4%+29.2%6.309%
8/15/2022Acuta Capital Partners LLC11,361,451$10.00M5.6%-3.2%5.498%
8/12/2022Dorsey & Whitney Trust CO LLC150,000$132K0.0%+100.0%0.073%
8/12/2022Franklin Resources Inc.9,448,954$8.32M0.0%-4.9%4.573%
7/29/2022Oak Family Advisors LLC390,742$344K0.2%+93.7%0.189%
7/29/2022SG Americas Securities LLC29,443$26K0.0%-75.3%0.014%
7/27/2022Assenagon Asset Management S.A.360,475$317K0.0%N/A0.174%


VTGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 40 institutional investors and hedge funds held shares of VistaGen Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($5.99M), Nantahala Capital Management LLC ($5.85M), Stempoint Capital LP ($4.83M), Great Point Partners LLC ($2.03M), Orbimed Advisors LLC ($1.75M), Two Sigma Investments LP ($1.03M), and JPMorgan Chase & Co. ($965K).Learn more on VistaGen Therapeutics' institutional investors.

78.39% of VistaGen Therapeutics' stock is owned by institutional investors. Learn more on VTGN's institutional investor holdings.

Of the 34 institutional investors that purchased VistaGen Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ADAR1 Capital Management LLC ($898.01K), JPMorgan Chase & Co. ($772.23K), Stempoint Capital LP ($528.40K), Nantahala Capital Management LLC ($464.28K), Luminus Management LLC ($350K), BlackRock Inc. ($345.43K), and Two Sigma Investments LP ($275.75K).

Institutional investors have bought a total of 2,498,501 shares in the last 24 months. This purchase volume represents approximately $2.42M in transactions.

The following institutional investors have sold VistaGen Therapeutics stock in the last 24 months: JPMorgan Chase & Co. ($954.07K), ADAR1 Capital Management LLC ($307.70K), Renaissance Technologies LLC ($261.22K), Ikarian Capital LLC ($101.79K), Blair William & Co. IL ($73.29K), Vanguard Group Inc. ($71.91K), and Boothbay Fund Management LLC ($62.45K).

Institutional investors have sold a total of 1,877,643 shares in the last 24 months. This volume of shares sold represents approximately $5.30M in transactions.



Institutional ownership data for NASDAQ:VTGN is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners